BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10738210)

  • 1. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients.
    Baldus SE; Zirbes TK; Hanisch FG; Kunze D; Shafizadeh ST; Nolden S; Mönig SP; Schneider PM; Karsten U; Thiele J; Hölscher AH; Dienes HP
    Cancer; 2000 Apr; 88(7):1536-43. PubMed ID: 10738210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer.
    Baldus SE; Zirbes TK; Glossmann J; Fromm S; Hanisch FG; Mönig SP; Schröder W; Schneider PM; Flucke U; Karsten U; Thiele J; Hölscher AH; Dienes HP
    Oncology; 2001; 61(2):147-55. PubMed ID: 11528254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
    Hanisch FG; Stadie T; Bosslet K
    Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms.
    Baldus SE; Hanisch FG; Kotlarek GM; Zirbes TK; Thiele J; Isenberg J; Karsten UR; Devine PL; Dienes HP
    Cancer; 1998 Mar; 82(6):1019-27. PubMed ID: 9506345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of carbohydrate antigen 19-9 in colorectal carcinoma.
    Shimono R; Mori M; Akazawa K; Adachi Y; Sgimachi K
    Am J Gastroenterol; 1994 Jan; 89(1):101-5. PubMed ID: 8273774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis.
    Mylonas I; Mayr D; Walzel H; Shabani N; Dian D; Kuhn C; Kunze S; Jeschke U; Friese K
    Anticancer Res; 2007; 27(4A):1975-80. PubMed ID: 17649808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
    Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival stratification panel of colorectal carcinoma with combined expression of carcinoembryonic antigen, matrix metalloproteinases-2, and p27 kip1.
    Li M; Li JY; Zhao AL; He JS; Zhou LX; Li YA; Gu J
    Dis Colon Rectum; 2007 Nov; 50(11):1887-98. PubMed ID: 17882488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
    Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
    Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mucin-associated carbohydrate core antigens in esophageal squamous cell carcinomas.
    Flucke U; Zirbes TK; Schröder W; Mönig SP; Koch V; Schmitz K; Thiele J; Dienes HP; Hölscher AH; Baldus SE
    Anticancer Res; 2001; 21(3C):2189-93. PubMed ID: 11501845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity of Thomsen-Friedenreich (TF) antigen in human neoplasms: the importance of carrier-specific glycotope expression on MUC1.
    Baldus SE; Hanisch FG; Monaca E; Karsten UR; Zirbes TK; Thiele J; Dienes HP
    Histol Histopathol; 1999 Oct; 14(4):1153-8. PubMed ID: 10506931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated antigen recognized by the 22-1-1 monoclonal antibody encourages colorectal cancer progression under the scanty CD8+ T cells.
    Oshikiri T; Miyamoto M; Morita T; Fujita M; Miyasaka Y; Senmaru N; Yamada H; Takahashi T; Horita S; Kondo S
    Clin Cancer Res; 2006 Jan; 12(2):411-6. PubMed ID: 16428480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer.
    Gulubova M; Vlaykova T
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1265-75. PubMed ID: 17645466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of tumor-associated antigen LEA and its significance for pathological diagnosis].
    Feng H; Song JD
    Ai Zheng; 2002 Jun; 21(6):658-62. PubMed ID: 12452070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.